心力衰竭患者的并发症预测100天内心血管复发-一项观察性研究
Mia Scholten1, Jason Davidge1,2, Björn Agvall1,3
1Center for Primary Health Care Research, Department of Clinical Sciences, Lund University, Lund, Sweden.
PloS one
|January 2, 2024
概括
患有心房动,慢性病或慢性阻塞性肺病的心力衰竭患者面临更高的再入院风险. 然而,仅仅这些并发症并不能完全预测再接收,这表明其他因素至关重要.
科学领域:
- 心脏病学 心脏病学
- 公共卫生 公共卫生
- 老年病的医生 老年病的医生
背景情况:
- 心力衰竭 (HF) 是心血管疾病的常见并发症,通常伴有并发症.
- 这些并发症显著影响HF患者的治疗结果和医院再入院.
- 了解并发症对HF再入院的影响对于改善患者护理至关重要.
研究的目的:
- 分析特定并发症对心血管相关再入院风险的影响,在HF患者退院后100天内.
- 为了确定哪些并发症可以独立预测再接收率的增加.
- 评估HF再接收的并发病的预测能力.
主要方法:
- 一项基于5029名高温患者 (2017-2019) 的基于人口的回顾性研究.
- 竞争风险回归和后勤回归分析了10种常见的并发症及其与100天再入院的关联.
- 接收器操作特征 (ROC) 和曲线下的面积 (AUC) 评估了模型的预测性能.
主要成果:
- 心房动,COPD,CKD,PAD和糖尿病最初与重新入院的增加有关.
- 在调整后,只有心房动,CKD和COPD仍然是重新入院的重要预测因素.
- 结合并发症的后勤回归模型显示AUC很低,这表明预测能力有限.
结论:
- 心房动,慢性病和慢性阻塞性肺部疾病与心力衰竭患者的再入院风险更高有显著联系.
- 来自ROC分析的低AUC表明,仅仅这些并发症是再接收的不足预测因素.
- 进一步的研究应该探索其他因素,有助于高频回收风险.
相关概念视频
01:17Pathophysiology of Heart Failure
1.6K
Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
1.6K
01:26Imbalances in Cardiac Output
1.4K
The heart's primary function is to pump blood throughout the body, maintaining a balance between blood sent out (cardiac output) and blood returning (venous return). If this balance is disrupted, it can result in congestive heart failure (CHF), a severe condition where the heart becomes an inefficient pump, leading to inadequate blood circulation.
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send...
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send...
1.4K
01:22Heart Failure Drugs: β-Blockers
341
β-adrenergic antagonists, commonly known as β-blockers, block the effects of sympathetic neurotransmitters such as noradrenaline (NA) and adrenaline (ADR). They have several beneficial effects in heart failure treatment. They reduce heart rate, the force of contraction, and cardiac muscle relaxation. They also slow the atrial-ventricular conduction rate and raise the threshold for arrhythmias. The concentration of β-blockers determines their effects on bronchodilation,...
341
01:26Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
433
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
433
01:22Heart Failure Drugs: Diuretics
388
Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
388
01:23Assessment of the Cardiovascular System I: Subjective Data
343
A thorough health history and physical assessment are essential for identifying cardiovascular disease (CVD) symptoms and distinguishing them from other health issues.
Initial Enquiry
Ask the patient about their primary concern and thoroughly explore all reported symptoms.
Medical History
Investigate past illnesses affecting the cardiovascular system, such as angina, anemia, rheumatic fever, congenital heart disease, stroke, thrombophlebitis, dysrhythmias, varicosities
Inquire about symptoms...
Initial Enquiry
Ask the patient about their primary concern and thoroughly explore all reported symptoms.
Medical History
Investigate past illnesses affecting the cardiovascular system, such as angina, anemia, rheumatic fever, congenital heart disease, stroke, thrombophlebitis, dysrhythmias, varicosities
Inquire about symptoms...
343